AOD-9604 is a modified growth-hormone fragment studied primarily in experimental lipid-metabolism models and analytical investigations of peptide breakdown.
Explore the research profileSubmit an unpaid laboratory order request for manual review. Availability and any pending amounts require confirmation.
Catalog quantities are not assay results.
Growth-hormone-derived peptide fragment
AOD-9604 contains the C-terminal 177–191 region of human growth hormone with an additional N-terminal tyrosine. This modified fragment is distinct from intact growth hormone. Its name and origin do not establish that it reproduces the full hormone's receptor activity or physiological effects.
This reference describes the published literature. Exact supplied form and chemical specifications require product-specific documentation. The studies are linked in Selected literature.
Animal studies investigated whether a limited growth-hormone-derived sequence could influence fat metabolism without reproducing selected glucose-related effects of the intact hormone. In the cited receptor experiments, AOD-9604 neither competed for growth-hormone receptor binding nor triggered the receptor-dependent proliferation response produced by growth hormone.
A study in obese Zucker rats measured weight gain, adipose lipolytic activity and insulin sensitivity. The reported metabolic changes provided an experimental rationale for further work, but outcomes in a genetically obese rat model cannot establish human weight-management efficacy. [1]
Experiments in obese and lean mice examined fat oxidation and energy-balance measures, alongside cell assays of growth-hormone receptor activity. The results support investigating fragment-specific biology instead of treating AOD-9604 as a smaller interchangeable form of growth hormone. [2]
Analytical work identified breakdown products after incubation in serum and urine and developed methods for detecting the parent peptide and selected metabolites. Such work addresses chemical identification and stability; it does not establish therapeutic benefit or clinical safety. [3]
Study topics describe the cited models, not established benefits of this catalog material.
The references selected here establish molecular identity, experimental metabolic activity and in vitro degradation behavior. They do not constitute successful human efficacy trials. Findings about insulin sensitivity in rodents should remain tied to the specific study conditions.
The receptor-level mechanism is not fully resolved by the cited experiments, and changes in animal fat oxidation are not equivalent to demonstrated human fat loss. Fragment stability and formulation differences further limit extrapolation. The papers do not substantiate cartilage-repair claims or verify any WYZ material's identity, purity or equivalence.
Primary studies and clearly identified supporting sources. Each link opens the original record.
Obese Zucker rat metabolism and insulin-sensitivity measurements.
Mouse energy balance and growth-hormone receptor assays.
Sequence identity, detection and serum/urine degradation; first published online in 2014.
Literature reviewed October 2026. This is a selected research overview, not an exhaustive systematic review. Published findings do not establish the identity, purity, sterility or suitability of any WYZ batch. For laboratory research only; not for human or veterinary use.
Final product specifications and product-specific storage instructions have not been supplied. Review the original documentation and your laboratory’s procedures before obtaining or using the material.
For qualified laboratory researchers. Not for human or veterinary use. Product information is not medical advice or a recommendation for personal use.
What to look for in a COAOther single compounds in the collection.
Metabolic Research
Retatrutide is a synthetic peptide studied for coordinated activation of three metabolic hormone receptors, with human research examining glucose regulation, appetite, body weight and liver fat.
Metabolic Research
MOTS-c is a mitochondrial-derived peptide studied in metabolic signaling and skeletal-muscle adaptation, with experimental interventions supported mainly by cell and animal evidence.
Dermal Research
GHK-Cu is a copper complex of glycyl-histidyl-lysine studied for its effects on extracellular-matrix production and remodeling in experimental tissue-repair systems.
